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Abstract
Infection of sheep with the gastric nematode Teladorsagia circumcincta results in distinct Th2-type changes in the
mucosa, including mucous neck cell and mast cell hyperplasia, eosinophilia, recruitment of IgA/IgE producing cells
and neutrophils, altered T-cell subsets and mucosal hypertrophy. To address the protective mechanisms generated
in animals on previous exposure to this parasite, gene expression profiling was carried out using samples of
abomasal mucosa collected pre- and post- challenge from animals of differing immune status, using an
experimental model of T. circumcincta infection. Recently developed ovine cDNA arrays were used to compare the
abomasal responses of sheep immunised by trickle infection with worm-naïve sheep, following a single oral
challenge of 50 000 T. circumcincta L3. Key changes were validated using qRT-PCR techniques. Immune animals
demonstrated highly significant increases in levels of transcripts normally associated with cytotoxicity such as
granulysin and granzymes A, B and H, as well as mucous-cell derived transcripts, predominantly calcium-activated
chloride channel 1 (CLCA1). Challenge infection also induced up-regulation of transcripts potentially involved in
initiating or modulating the immune response, such as heat shock proteins, complement factors and the
chemokine CCL2. In contrast, there was marked infection-associated down-regulation of gene expression of
members of the gastric lysozyme family. The changes in gene expression levels described here may reflect roles in
direct anti-parasitic effects, immuno-modulation or tissue repair. (Funding; DEFRA/SHEFC (VT0102) and the BBSRC
(BB/E01867X/1)).
Introduction
Parasitic gastroenteritis (PGE), caused by trichostrongy-
lid nematodes, is the most commonly diagnosed sys-
temic disease of sheep in the U.K. The principal
causative nematode is the abomasal parasite Teladorsa-
gia circumcincta. Control currently depends on the use
of anthelmintics, but is failing due to the rapid emer-
gence of drug resistance in the target nematodes [1].
Immunity builds up slowly on repeated exposure to the
parasite, indicating vaccination could be a feasible alter-
native, but vaccine development is hampered by a lack
of knowledge of the host-parasite interaction to infective
larvae. This immunity can be replicated experimentally
by giving animals a low level trickle infection over sev-
eral weeks, which results in a significant level of protec-
tive immunity to T. circumcincta challenge, measurable
by reduced worm burdens, stunting of the worms and
increased levels of larval arrest [2-4]. Protective immu-
nity includes both cellular and humoral components;
previously exposed animals undergo a local blast cell
response in the draining lymphatics which can convey
protection to genetically identical naïve recipients [2,5],
while local IgA/IgE responses have been associated with
certain protective responses such as stunted growth and
reduced fecundity of the worms [4,6,7]. T. circumcincta
c h a l l e n g ei np r e v i o u s l yi m m u n i s e ds h e e pe l i c i t sl o c a l
predominantly Th2 cytokine expression, compared to a
more Th1-bias in naïve animals [8,9]. This response is
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mucosa, such as mucous neck cell and mast cell hyper-
plasia, eosinophilia, recruitment of IgA/IgE producing
cells and neutrophils, altered T-cell subsets and mucosal
hypertrophy [10-14]. However, the molecular changes
involved, and the relative contributions of these factors
to both control of infection and the clinical symptoms
of disease, are still poorly understood. The host immune
responses may act concordantly to generate an unfa-
vourable micro-environment [15], which could involve
generation of specific antibodies to reduce worm
fecundity or feeding [6,7], or promote rapid expulsion
[16]. To identify the molecular changes generated in the
abomasal mucosa in animals after previous exposure to
this parasite, gene expression profiling was carried out
using ovine cDNA microarrays on samples of abomasal
mucosa collected pre- and post-challenge from animals
of differing immune status. The significance of the key
changes observed is discussed.
Materials and Methods
All experimental research described in this manuscript
was carried out in accordance with Moredun Research
Institute, Roslin Institute and R(D)SVS guidelines. All
experimental protocols were approved by the Moredun
Research Institute Experiments and Ethical Review
Committee and authorised under the UK Animals
(Scientific Procedures) Act 1986.
Infections and sample collection
A series of experimental trials were set up to compare
the immune responses of “previously infected” yearling
sheep immunised by an eight-week trickle infection
(referred to subsequently as “immune” throughout this
manuscript), with worm-free naïve yearling sheep, at dif-
ferent timepoints post-challenge with a single dose of 50
000 T. circumcincta L3. The details of these infection
trials are summarised in Table 1. All sheep were housed
under worm-free conditions. Previously described work
has established that there were significant differences in
anti-parasite responses between the “naïve” and
“immune” groups used in this study [4,11]. Samples of
host material collected post-mortem included abomasal
fold (anterior to the fundic region) for RNA extraction
[17]. RNA was extracted as described previously [17]
and assessed for quality and quantity using an Agilent
2100 Bioanalyzer (Agilent Technologies UK Ltd, Edin-
burgh, U.K.) according to ARK-Genomics standard pro-
tocols [18].
Hybridisations and statistical analysis
Ovine cDNA microarrays (ARK-Genomics O. aries 12 K
v1.0) were generated at ARK-Genomics using PCR-
amplified products from individual cDNA clones predo-
minantly from the KN511 library; a normalised cDNA
library generated from gastrointestinal tract and lym-
phoid tissues of worm-free and T. circumcincta infected
sheep, supplemented with an existing sheep/brain library
[19]. Expressed Sequence Tags (ESTs) for each cDNA
clone have been deposited in the EMBL/Genbank public
DNA sequence databases. The array was annotated on
the basis of homologous bovine sequences using Uni-
gene, DfCI Gene Index, Ensembl cDNA library and the
International Protein Index.
In order to characterise responses at day 5 (Expt.1)
and day 0/day 2 (Expt. 2) post-challenge (Table 1), RNA
samples were fluorescently labelled and competitively
hybridised to the ovine cDNA microarrays using ARK-
Genomics standard protocols [18]. Samples were paired
in a dye-balanced arrangement as indicated in Table 2.
The groups of samples being paired will be termed
throughout this manuscript as Nvd5/Nvd0 (i.e. naive
day 5 post-challenge vs. day 0 (unchallenged)), Imd5/
Nvd5 (i.e. immune vs. naive day 5 post-challenge),
Imd0/Nvd0 (i.e. immune vs. naive day 0 (unchallenged))
and Nvd2/Nvd0 or Imd2/Imd0 (i.e. naive or immune
Table 1 Design of T. circumcincta infection trials in yearling sheep
Trial Group Treatment Days post-challenge
a; no. of sheep
Trickle infn
b clearance
c 0
d 251 02 1
Expt. 1 Naïve (Nv) - + 6 - 6 6 6
Immune (Im)
e ++ - - 6 6 -
Expt. 2 Naïve (Nv) - + 6 6 - - -
Immune (Im)
e ++ 6 6 - - -
The experimental model of infection used in this study is summarised. Details are given in the footnotes. Two experimental trials were carried out; Expt.1;
addressing differences between immune ("previously infected”) and naïve sheep at days 5 and 10 post challenge, and Expt.2, addressing differences between
immune and naïve and sheep without challenge (day 0) and early post-challenge (day 2).
a1 × 50 000 T. circumcincta L3 on Day 0
b2000 T. circumcincta L3 3 × per wk for eight weeks
cLevamisole (7.5 mg/kg) 7 days before challenge
dDay 0 = unchallenged
epreviously infected by trickle infection
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shown in Table 2. Scanning and data capture using
Bluefuse feature extraction software (BlueGnome Lim-
ited, Cambridge, United Kingdom) was undertaken
according to ARK-Genomics standard protocols [18].
Log2 (intensity ratios) were subjected to spatial and
intensity dependent normalisations to remove technical
bias by spatial row and column averaging [20] and M-A
lowess correction [21]. Means of normalized gene log2
(intensity ratios) were compared for treatment effects
and treatment-by-dye interactions by ANOVA followed
by t-tests, using modifications of the Limma package
[22]. Statistical analysis to generate gene lists was based
on each sample coming from a different sheep, and fit-
ting the two (Expt. 1) or three (Expt. 2) dye-balanced
arrangements with a common error variance. T-tests
were modified by the Limma eBayes correction [23].
Genes with Benjamini & Hochberg false discovery rate ≤
0.05 [24] were considered to show significantly different
expression levels. Normalisations and analyses were
weighted by the Bluefuse “confidence” measure [25].
Subsets of the data from Expt. 2; genes whose expres-
sion levels were significantly changed (FDR ≤ 0.05) ≥ 1.5
fold from the Imd0/Nvd0 and Imd2/Imd0 gene lists
(Table 1)); were analyzed through the use of Ingenuity
Pathways Analysis (Ingenuity
® Systems (Redwood City,
CA, U.S.A) [26]) by inputting human gene symbols
(HUGO) for their putative ovine orthologues.
RT-PCR and multiplex qRT-PCR analysis
Subsequent validation assays for selected groups of
genes whose expression levels were significantly changed
(FDR ≤ 0.05) ≥ 2 fold were carried out initially by semi-
quantitative RT-PCR and sequence analysis of products
to confirm identity. Methods for reverse transcription,
polymerase chain reaction and purification of PCR pro-
ducts have been described previously [17,27]. Gene-spe-
cific primers were designed from the ovine sequences
(ESTs) for the relevant KN511 cDNA clones, or
previously published sequences, using the Primer 3 pro-
gram; [28]. Primers and PCR conditions for RT-PCR are
shown in Additional file 1: Table S1. Three “housekeep-
ing” genes found to show no significant change in any
of the array analyses (ATPase, RW1 and TM57; Table 3)
were used as positive controls. Sequence analysis of PCR
products was carried out using multiple alignment and
sequence similarity search programs available on [29,30]
and [31].
In order to provide quantitative data on gene expression
for the transcripts investigated above, two multiplex
competitive qRT-PCR assays were designed from pub-
lished sequences as summarised in Table 3; which
included a total of 21 study genes and 3 “housekeeping”
genes. Multiplex competitive qRT-PCR assays were
designed by Sequenom Inc. (San Diego, CA, USA) using
QGE assay designer software, version 3.4 (Sequenom
®
MassARRAY
® System; [32]. These assays were used to
compare levels of transcripts for each gene in naïve
sheep with immune sheep at days 0, 2, 5 and 10 and 21
post-challenge, by running the multiplex qRT-PCR
assays with cDNA from all 60 RNA samples sum-
marised in Table 1. The assays and data collection were
carried out using Sequenom standard protocols for
quantitative gene expression [33]. Significant differences
were identified using the Mann-Whitney U-test for non-
parametric data.
Results
Results of microarray analysis
The numbers of transcripts that exhibited significant
changes in expression levels (Benjamini & Hochberg
FDR ≤0.05) in Expts. 1 and 2 are summarised in the
Venn diagrams in Figure 1, and in Additional file 1
Table S2. In both experiments, the highest numbers of
transcripts showing significantly altered expression
levels (approx > 2K) were associated with the challenged
immune group (day 2 or day 5) compared to day 0 of
the same group, or compared to naive animals at the
same timepoint post-challenge (Figure 1a and 1b).
There were no significantly differentially expressed
genes in the Nvd2/Nvd0 comparison from Expt. 2. Any
transcripts showing significant (FDR ≤ 0.05) treatment-
by-dye interactions (Additional file 1: Table S2; Expt. 2)
were removed from the gene lists. This precautionary
measure excluded pairs of treatment estimates (from
cy5-cy3 or cy3-cy5 dye orientations) with conflicting
signs and some pairs of treatment estimates with the
largest proportionate differences in magnitude (graphs
not presented). The complete gene lists of significantly
differentially expressed genes, with significant treat-
ment-by-dye interactions excluded, are available under
Array Express [34] or by contacting the authors. Data
from Expt. 2 were analysed through the use of
Table 2 Hybridisation design
Experiment Hybridisations (d = days post-challenge)
Expt. 1 Nvd0/Nvd5 Nvd5/Imd5
Day 5 post-challenge (n =6 ) ( n =6 )
Expt. 2 Nvd2/Nvd0 Imd0/Nvd0 Imd2/Imd0
Day 2 post-challenge (n =5
a)( n =5
a)( n =5
a)
Samples in both cDNA hybridisation experiments were paired as indicated with
a dye-balanced arrangement (three cy3/cy5 & three cy5/cy3 hybridisations). Nv
= “naïve” yearlings, worm naïve prior to challenge; Im = “immune” yearlings,
previously infected by trickle infection prior to challenge (see Table 1).
Common samples linked the sets of paired hybridisations (Expt 1: Nvd5
samples, Expt. 2: Nvd0 & Imd0 samples). An indirect comparison between the
results from all three hybridisations gave the (Nvd2/Nvd0)/(Imd2/Imd0) gene
list.
aOne chip failed hybridisation QC in Expt 2 and so was removed from the
analysis, along with chips linked to it.
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Page 3 of 22Figure 1 Venn diagrams to illustrate total numbers of genes whose expression levels were significantly altered (FDR ≤ 0.05) detected
in each hybridisation experiment; 1a) Expt.1; day 5 post-challenge 1b) Expt. 2; day 2 post-challenge.N v=“naïve” yearlings, worm naïve
prior to challenge; Im = “immune” yearlings, previously infected by trickle infection prior to challenge; d0, d2, d5 = days post-challenge; (details
in Table 1). The figures in the circled regions correspond to the number of genes with significantly altered (FDR ≤ 0.05) expression levels in each
comparison (details given in Table 2) while the figures in the overlapping regions correspond to the number of genes whose expression levels
were significantly altered (FDR ≤ 0.05) in two or more comparisons; eg. 8 genes showed significantly altered expression levels in both the Imd2/
Imd0 and Imd0/Nvd0 comparisons. The figures outside the circled regions correspond to the numbers of genes on the array with no significant
change in expression level in any of the comparisons.
Table 3 Details of gene sequences, and likely function, selected for further analysis
Functional Category Gene Name Clone/probe ID on KN511 cDNA array EMBL acc. no. Assay
Cytotoxicity GNLY C0009264H11.P1KAM13F FE028690 W1
CatC sh1-aoo11_l0.s2 DY479012 W2
GZMA KN511_9486f02 FE037399 W2
GZMB KN511_9253n09 FE021442 W1
GZMH KN511_9260m05 FE026184 W2
Mucus composition CLCA1 020502OAPP1012080HT OAPP EE748540 W1
ITLN1 -
a AM087961 W2
ITLN2 KN511_9264a24.p1kaM13F EF521881 W2
ITLN3 -
a AM888394 W2
Heat shock response HSPA8 KN511_9479o03 DY491193 W1
HSPCA KN511_9253c04 FE020983 W2
ST1 KN511_9486e08 FE037366 W1
Proinflammatory response PLA2G2A KN511_9482g22 FE034658 W1
CF1 KN511_9257m10 FE024140 W1
CCL2 KN511_9477e07 FE031007 W1
Tissue remodelling MMP13 KN511_9487m11.p1kM13F AY091604 W1
MMP23 sh1-bjd04_l0.s2 DY483383 W2
CST3 KN511_9476g20 FE030675 W1
Digestion LZM1A KN511_9487n22.p1kM13F
b M32492 W1
LZM4A KN511_9487n22.p1kM13F
b M32497 W1
Unknown MALAT KN511_9484l14 FE036272 W1
“Housekeeping” genes ATPase KN511_9488b23.p1kM13F X02813 W1/W2
RW1 KN511_9261h17 FE026635 W1/W2
TM57 KN511_9488i21 FE030125 W1/W2
The EMBL accession no. for the sequences used to design multiplex competitive qRT-PCR assays (Sequenom
® MassARRAY
® System) is given, together with the
representative probe on the ovine cDNA array. The two multiplex competitive qRT-PCR assays were designated W1 and W2 as indicated.
aOnly ITLN2 was represented on the arrays.
bThese cDNA probes would not be able to distinguish between LZM1A, 3A and 4A.
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Page 4 of 22Ingenuity Pathways Analysis (Ingenuity
® Systems, [26]).
Data were analysed from two datasets of genes whose
expression levels were significantly changed (FDR ≤
0.05) ≥ 1.5 fold in Expt. 2 (see Table 2): Imd0/Nv d0; to
highlight changes induced by trickle infection immuni-
sation, and Imd2/Imd0; to highlight early (<48 h)
changes induced following challenge of immunised ani-
mals. For each differentially expressed ovine transcript
of interest the gene identifier (HUGO) for the putative
orthologous human gene and the transcript’s expression
value were uploaded into the application. The output of
the top 20 most significant (Fisher’s exact test) biologi-
cal functions are shown in Figure 2. Significant net-
works (P ≤ 10
-10;F i s c h e r ’s exact test) identified from
the Imd0/Nvd0 and Imd2/Imd0 datasets from Expt. 2
are shown in Additional file 2 Table S3. Pathways were
identified from the Ingenuity Pathways Analysis (Inge-
nuity
® Systems, [26]) library of canonical pathways that
were most significant to the data set. The top 20 most
significant canonical pathways from the Imd0/Nvd0 and
Imd2/Imd0 datasets from Expt. 2 are shown in Addi-
tional file 2 Table S4.
The biological function associated with the most sig-
nificant changes (Figure 2) in the Imd0/Nvd0 compari-
son was “Cell Cycle”, which also features as the most
significant network (Additional file 2 Table S3) probably
reflecting the increased cellular turnover occurring in
the immune versus naïve abomasum. “Cancer” was the
most significant function from the Imd2/Imd0 compari-
son, which is likely to relate to increased transcription
factor activity following challenge of the immunised
sheep. It is notable that the functions “Inflammatory
Disease”, Immunological Disease”, “Infectious Disease”
and “Cell-mediated Immune Response” were identified
in the Imd2/Imd0 comparison only, which is indicative
of increased innate and adaptive immune responses
within 48 h following challenge. The most significant
network from the Imd2/Imd0 comparison is “Hematolo-
gical Disease, Small Molecule Biochemistry, Cellular
Compromise” (Additional file 2 Table S3); further
Figure 2 The top 20 most significant biological functions identified from the Imd0/Nvd0 and Imd2/Imd0 datasets from Expt. 2, using
Ingenuity Pathways Analysis software (Ingenuity
® Systems, [26]). The Functional Analysis identified the biological functions and/or diseases
that were most significant to the data set. Right-tailed Fisher’s exact test was used to calculate a P-value determining the probability that each
biological function and/or disease assigned to that data set is due to chance alone.
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the most significant pathways within this network were
the “Complement System”, “Granzyme B signalling” (i.e.
Granzyme B pathway), “Huntington’s Disease signalling”
and “NRF2-mediated oxidative stress response"; the lat-
ter two pathways predominantly involve heat shock pro-
teins. It is notable that NFkB signalling predominated in
many of the pathways within this network. The 20 most
significant pathways from the whole Imd0/Nvd0 and
Imd2/Imd0 datasets are shown in Additional file 2
Table S4.
The 20 most significantly (FDR ≤ 0.05) up- and down-
regulated transcripts from both experiments are shown
in Tables 4 (up-regulated transcripts) and 5 (down-regu-
lated transcripts). Fold cha n g e so fas e l e c t i o no ft h e s e
transcripts, grouped under possible function, are illu-
strated diagrammatically in Figure 3. Transcripts of par-
ticular biological interest, listed in Table 3, were
selected for further investigation, initially by semi-quan-
titative RT-PCR (Additional file 1 Table S1) and
sequence analysis to validate expression in the aboma-
sum and sequence identity (data not shown) and subse-
quently, by multiplex competitive qRT-PCR analyses
(Table 3). The aims of these assays were to validate the
key findings from the array analysis (Figure 3), and to
examine temporal changes in response to challenge
infection in both the naïve and immune groups, using
samples collected at post-mortem on days 0-21 post-
challenge as summarised in Table 1. The results of the
multiplex qRT-PCR analyses are shown in Figures 4, 5,
6 and 7. The results are discussed below in the context
of transcripts specific to particular cell types and/or
likely to share a similar function.
Transcripts normally associated with cells exhibiting
cytotoxicity
Transcripts for granulysin were identified as the most
highly up-regulated in immune sheep (+94 fold), com-
pared with naïve at day 5 post-infection (p.i.) (Table 4;
Figure 3), and were confirmed to show significantly
(FDR ≤ 0.05) highly up-regulated expression in immune
animals at all timepoints post-challenge by multiplex
qRT-PCR (Figure 4). We also observed a +2-5 fold up-
regulation of transcripts for granzymes A, B and H in
immune animals on day 5 post-challenge compared
with naïve, and a >7 fold up-regulation of cathepsin C
transcripts in immune animals on day 2 after challenge
compared to naïve or to day 0 (Figure 3a). Results from
the multiplex qRT-PCR analysis showed significantly
higher numbers of transcripts for granzymes A and H in
immune abomasal samples compared to naïve at day 5
post-challenge, with elevated levels persisting at day 10,
but expression of granzyme B was highly variable and
not significant (Figure 4). Transcripts for cathepsin C
were generally 10-fold more abundant in challenged ani-
mals at days 5-21 compared to day 0, although there
were no significant differences between the immune and
naïve groups (Figure 4). The 20 most significant path-
ways identified from the Imd2/Imd0 comparison
included “Crosstalk between Dendritic cells and NK
cells”, “Granzyme B Signalling” and “Leukocyte Extrava-
sation Signalling”, indicative of an increased cell-
mediated immune response (Additional file 2 Table S4).
Mucous-cell associated transcripts
The mucous-cell associated transcript calcium-activated
chloride channel 1 (CLCA1)w a so n eo ft h em o s tu p -
regulated transcripts seen in immune sheep in both
experiments. CLCA1 was the second most up-regulated
transcript in immune versus naïve sheep day 5 post-
challenge (Expt. 1) and was also among the most up-
regulated transcripts in the immune versus naïve sheep
at day 0 and day 2 post-challenge (Expt 2) (Table 4,
Figure 3b)). Significant (FDR ≤ 0.05) up-regulation of
CLCA1 transcripts in immune versus naïve sheep was
confirmed in the multiplex qRT-PCR analysis (day 5
post-challenge, Figure 5) and there was a general up-
regulation of expression in response to challenge
(i.e. compared to day 0) in both groups, significant (P ≤
0.01) in naïve animals on days 5-21. We also observed
significant up-regulation of transcripts for the mucous
cell product trefoil factor 3 (TFF3)i ni m m u n ea n i m a l s
compared to naïve (Table 4; Figure 3b)), while trefoil
factor 2 (TFF2) was highly down-regulated (Table 5).
While members of the intelectin family, galactose-
binding lectins expressed by mucous neck cells [27], did
not feature in the lists of significantly up-regulated
genes from the microarray analysis (only ITLN2
(KN511_9264a24.p1kaM13F) was represented on the
array), specific assays for all three of these genes were
included in the multiplex qRT-PCR analysis as a positive
control, since ITLNs 1, 2 and 3 have been shown to be
up-regulated in abomasal mucosa in response to T. cir-
cumcincta [35]. There was a significant up regulation in
response to challenge in the naïve group for all 3 inte-
lectins, with earlier up-regulation of ITLN-3 than ITLN-
1 and -2, although these assays did not show significant
differences between naïve and immune sheep (Figure 5).
We also observed infection-associated up-regulation of
transcripts for two galectins, which belong to the C-type
lectin family; galectin 1 (+1.5 fold), and galectin 4 (+1.6
fold).
Mast -cell associated transcripts
Significantly (FDR ≤ 0.05) up-regulated gene expression
of the high affinity IgE receptor in immune animals was
detected on day 2 (+1.5 fold) and day 5 (+1.8 fold) post-
challenge, compared to the naïve group at the same
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Page 6 of 22Table 4 The 20 most up-regulated transcripts detected in Expts. 1 and 2 (FDR ≤ 0.05)
Sequence.ID TIGR_TC TC. description Gene
symbol
Fold
Change
EXPT 1. Comparison = Nvd5/Nvd0
KN511_9480n02.p1kaM13F TC385850 — — 5.44
C0009213B13 —— — 1.81
KN511_9261j08.p1kaM13F —— — 1.77
KN511_9255d18.p1kaM13F TC307335 laminin B1 LAMB1 1.64
KN511_9486f02.p1kM13F TC305120 UP|GRAA_BOVIN (Q7YRZ7) Granzyme A precursor, complete gzmA 1.59
KN511_9488i01.p1kM13F TC311345 homologue to UP|Q96IL1_HUMAN (Q96IL1) DIAPH1 protein (Fragment), partial
(43%)
LOC786565 1.55
KN511_9483h09.p1kM13F TC302202 UP|Q3T119_BOVIN (Q3T119) FCGRT protein, complete FCGRT 1.53
CN822687 TC381381 similar to emb|X79547.1|MIECCOMP Equus caballus mitochondrial DNA complete
sequence, partial (4%)
— 1.52
KN511_9257n17.p1kaM13F —— — 1.52
KN511_9479d15.p1kaM13F TC361081 similar to UP|O97916_BOVIN (O97916) Reverse transcriptase-like, partial (43%) — 1.51
KN511_9486m17.p1kM13F TC303503 UP|C1QA_BOVIN (Q5E9E3) Complement C1q subcomponent subunit A precursor,
complete
C1QA 1.50
KN511_9257l13.p1kaM13F —— — 1.50
KN511_9479o01.p1kaM13F TC355858 GB|AAI02065.1|74353831|BC102064 CCL5 protein {Bos taurus} (exp = -1; wgp = 0; cg
= 0), complete
CCL5 1.50
CN823601 TC342786 — — 1.50
KN511_9486d22.p1kM13F TC337098 UP|Q3SZV9_BOVIN (Q3SZV9) Heat shock 10kDa protein 1 (Chaperonin 10), complete HSPE1 1.50
KN511_9477j24.p1kaM13F TC301808 UP|Q3ZC91_BOVIN (Q3ZC91) Sphingomyelin phosphodiesterase, acid-like 3A,
complete
LOC781963 1.48
KN511_9485e22.p1kM13F —— — 1.48
KN511_9253n18.p1kaM13F TC317864 UP|Q3KZ51_SCHJA (Q3KZ51) SJCHGC03568 protein (Fragment), partial (6%) MGC139367 1.48
KN511_9265g17.p1kaM13F TC319596 homologue to UP|TCEA3_HUMAN (O75764) Transcription elongation factor A
protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation
factor TFIIS.h), complete
MGC137536 1.48
KN511_9265b23.p1kaM13F —— — 1.48
EXPT 1 Comparison = Imd5/Nvd5
KN511_9264h11.p1kaM13F TC331976 homologue to UP|Q864L7_BOVIN (Q864L7) Granulysin/NK-lysin-like protein
(Fragment), complete
GNLY 94.0
KN511_9257k12.p1kaM13F —— — 5.91
KN511_9263m23.p1kaM13F TC306994 similar to UP|Q9TUB5_PIG (Q9TUB5) Epithelial chloride channel protein, partial (95%) CLCA1 5.15
KN511_9253n09.p1kaM13F TC328399 similar to UP|Q67BC3_HUMAN (Q67BC3) Endogenous granzyme B, partial (90%) LOC508646 5.14
KN511_9265g07.p1kaM13F TC351879 — LOC614719 4.70
KN511_9260m05.p1kaM13F —— — 4.64
KN511_9260b08.p1kaM13F TC330838 — — 4.27
CN823175 —— — 3.14
CN823115 TC329726 homologue to GB|CAA44699.1|440|BTIGG1HCX anti-testosterone antibody {Bos
taurus} (exp = -1; wgp = 0; cg = 0), partial (70%)
IGHG1 2.72
KN511_9480o15.p1kaM13F —— — 2.66
KN511_9476e05.p1kaM13F TC330547 similar to UP|NBR1_PONPY (Q5RC94) Next to BRCA1 gene 1 protein (Neighbor of
BRCA1 gene 1 protein), partial (23%)
LOC515032 2.64
KN511_9486a03.p1kM13F TC350940 similar to UP|CAD26_MOUSE (P59862) Cadherin-like protein 26 precursor, partial
(11%)
LOC617096 2.47
CO202749 TC366134 similar to UP|Q48MR5_PSE14 (Q48MR5) Uncharacterized protein family UPF0016,
partial (58%)
— 2.45
KN511_9486o13.p1kM13F TC322636 weakly similar to UP|Q9R0M7_MOUSE (Q9R0M7) Aldo-keto reductase AKR1C12,
partial (91%)
LOC507734 2.42
CN824147 —— — 2.38
CN823337 TC313767 UP|Q2FLD4_METHJ (Q2FLD4) ABC transporter related, partial (6%) — 2.37
CO203065 TC321552 — — 2.34
KN511_9487e05.p1kM13F TC302266 GB|AAC67307.1|1930063|BTU92535 neuronal axonal membrane protein {Bos taurus}
(exp = -1; wgp = 0; cg = 0), complete
BASP1 2.30
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KN511_9261f23.p1kaM13F —— — 2.29
KN511_9478a01.p1kaM13F TC347423 similar to UP|GRAH_HUMAN (P20718) Granzyme H precursor (Cytotoxic T-
lymphocyte proteinase) (Cathepsin G-like 2) (CTSGL2) (CCP-X) (Cytotoxic serine
protease C) (CSP-C), partial (93%)
LOC617313 2.28
KN511_9486l10.p1kM13F TC315163 similar to GB|AAH12303.1|15126763|BC012303 PDZK1 interacting protein 1 {Homo
sapiens} (exp = -1; wgp = 0; cg = 0), complete
PDZK1IP1 2.21
CN824077 —— — 2.21
CN824594 TC359921 homologue to UP|Q4K9Y4_PSEF5 (Q4K9Y4) BNR/Asp-box repeat protein, partial
(41%)
— 2.14
KN511_9260m24.p1kaM13F —— — 2.13
EXPT 2 Comparison = Imd0/Nvd0
KN511_9484k05.p1kM13F TC323139 similar to UP|Q4TA31_TETNG (Q4TA31) Chromosome undetermined SCAF7459,
whole genome shotgun sequence, partial (10%)
— 3.59
KN511_9263m23.p1kaM13F TC306994 similar to UP|Q9TUB5_PIG (Q9TUB5) Epithelial chloride channel protein, partial (95%) CLCA1 2.99
KN511_9484p11.p1kM13F —— — 2.08
KN511_9485e08.p1kM13F TC312631 — — 1.61
KN511_9478a06.p1kaM13F TC312631 — — 1.49
KN511_9481c23.p1kaM13F TC314684 — — 1.46
CN823114 TC301217 homologue to UP|NDRG1_HUMAN (Q92597) Protein NDRG1 (N-myc downstream-
regulated gene 1 protein) (Differentiation-related gene 1 protein) (DRG-1) (Reducing
agents and tunicamycin-responsive protein) (RTP) (Nickel-specific induction protein
Cap43) (Rit42), partial (97%)
NDRG1 1.37
KN511_9257n17.p1kaM13F —— — 1.35
CN823685 TC315004 similar to UP|Q3TT48_MOUSE (Q3TT48) Adult male pituitary gland cDNA, RIKEN full-
length enriched library, clone:5330433L19 product:proprotein convertase subtilisin/
kexin type 2, full insert sequence. (Fragment), partial (3%)
LOC615685 1.33
KN511_9476g20.p1kaM13F TC337413 UP|CYTC_BOVIN (P01035) Cystatin C precursor (Colostrum thiol proteinase inhibitor),
complete
CST3 1.31
—— — 1.30
KN511_9259b18.p1kaM13F TC371167 — — 1.29
KN511_9479a08.p1kaM13F TC318244 UP|CATA_BOVIN (P00432) Catalase, partial (5%) MGC128112 1.29
CN823587 —— — 1.27
CO202780 TC357183 UP|Q71V68_MOUSE (Q71V68) Ldb1a, complete LOC526472 1.26
KN511_9262a18.p1kaM13F TC308953 UP|Q3T013_BOVIN (Q3T013) BCL2/adenovirus E1B 19kDa interacting protein 3-like,
partial (84%)
BNIP3L 1.26
CO202648 TC301621 homologue to UP|Q9HB23_HUMAN (Q9HB23) Lysyl-tRNA synthetase, complete MGC127504 1.25
KN511_9254i12.p1kaM13F TC381609 homologue to UP|Q963G4_PLAFA (Q963G4) MB2 (Fragment), partial (3%) LOC508133 1.25
KN511_9261e18.p1kaM13F —— — 1.24
EXPT 2 Comparison = Imd2/Imd0
KN511_9481e19.p1kaM13F TC318483 — LRIG1 10.2
KN511_9256h20.p1kaM13F TC309152 similar to UP|O97916_BOVIN (O97916) Reverse transcriptase-like, partial (19%) — 10.0
KN511_9257i19.p1kaM13F TC375873 — — 9.71
KN511_9481f19.p1kaM13F TC345827 homologue to GB|CAI11042.1|55859631|AL353665 match: proteins: Q92802 {Homo
sapiens} (exp = 0; wgp = 1; cg = 0), partial (35%)
LOC541201 9.17
KN511_9480f18.p1kaM13F —— — 8.94
CN822322 TC309241 nucleolin [Bos taurus] NCL 8.03
KN511_9483a22.p1kM13F TC316336 UP|Q3ZCJ8_BOVIN (Q3ZCJ8) Cathepsin C, complete CTSC 7.52
KN511_9263m23.p1kaM13F TC306994 similar to UP|Q9TUB5_PIG (Q9TUB5) Epithelial chloride channel protein, partial (95%) CLCA1 7.33
KN511_9483l13.p1kM13F TC340529 homologue to UP|Q9BTX0_HUMAN (Q9BTX0) RNA binding motif protein 10,
isoform 2, partial (69%)
RBM10 6.73
KN511_9488g12.p1kM13F TC304325 similar to GB|CAJ18388.1|71059689|CT010180 {Mus musculus} (exp = -1; wgp = 0; cg
= 0), complete
MGC127625 6.46
KN511_9263i18.p1kaM13F TC332274 UP|Q7ZU59_BRARE (Q7ZU59) H2AV protein (Fragment), partial (87%) H2AFZ 6.45
KN511_9253j02.p1kaM13F TC331773 homologue to UP|HSP76_PIG (Q04967) Heat shock 70 kDa protein 6 (Heat shock 70
kDa protein B’), complete
HSPA6 6.11
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Page 8 of 22timepoints. Up-regulated expression of cathepsin C,
another potential mast cell transcript, has already been
mentioned in the previous section. SMCP-1 and tryp-
tase, which are expressed by abomasal mucosal mast
cells during nematode infection [36,37], did not feature
on this array.
Heat shock proteins
Significant up-regulation of a number of transcripts for
heat shock proteins was detected in both microarray
experiments. Transcripts for the heat shock proteins
HSP1A (HSP70 protein 1A) and HSPA6 (HSP 70 protein
6) feature among some of the most significantly (FDR ≤
0.05) highly up-regulated transcripts detected in
immune sheep, up-regulated (+3-7 fold) by day 2 post-
challenge in this group in comparison to naive (Figure
3c) and Table 4). The STIP1 (HSP70/90 organising pro-
tein; HOP) and HSPA8 (HSP70 protein 8) genes also
appear to show significantly up-regulated expression in
immune animals compared to naïve (+1.5-2 fold) (Figure
3c) and Table 4). Transcripts for HSPCA (HSP90a)
appear to show significantly (FDR ≤ 0.05) increased
levels on day 2 post-challenge in immune animals,
although the expression pattern varies across the differ-
ent comparisons (Figure 3c) and Table 4). The most sig-
nificant network identified in the Imd2/Imd0
comparison (Network 1;"Cellular Compromise"; Addi-
tional file 2 Table S3) links STIP1 with a number of
heat shock proteins in the HSP70/90 family. Multiplex
qRT-PCR analysis showed that transcripts for STIP1
were significantly (P ≤ 0.01-0.05) increased day 5-21
post-challenge in the naïve group, with a similar trend
in immune sheep, although there were no immune day
0 animals within the same trial (Figure 6). Multiplex
qRT-PCR analysis, however, did not support all the
findings for HSPA8 and HSPCA, although there was a
significant (P ≤ 0.05) challenge-associated increase in
levels of HSPA8 transcripts in the naïve group by day 10
(Figure 6).
Transcripts associated with pro-inflammatory responses
The microarray analyses demonstrated significant (FDR
≤ 0.05) up-regulation of a number of transcripts asso-
ciated with eicosanoid metabolism. Transcripts for
PLA2G2A, which liberates arachidonic acid from phos-
pholipids, were significantly up-regulated in response to
challenge (+3 fold), and in immune animals compared
to naïve at day 2 and day 5 post-challenge (+1.5-2 fold)
(Figure 3d). The multiplex qRT-PCR analysis showed
significant (P ≤ 0.05) up-regulation of PLA2G2A tran-
scripts at day 5 post-challenge, but did not show signifi-
cant differences between the naïve and immune groups
(Figure 6). Transcripts for prostaglandin E synthase
(CPGES), another member of this pathway, appear to be
significantly (FDR ≤ 0.05) up-regulated (+1.6 fold) in
immune animals by day 2 post-challenge compared to
naïve animals. “Arachidonic Acid Metabolism” features
among the significant pathways from the Imd0/Nvd0
comparison (Additional file 2 Table S4).
Transcripts for the chemokine CCL2 (MCP-1) were
significantly up-regulated >2 fold on day 2 post-chal-
lenge in immune sheep, compared to naïve or unchal-
lenged sheep (Figure 3d). Multiplex qRT-PCR analysis
showed that transcripts for CCL2 were significantly (P ≤
0.01-0.05) increased day 10-21 post-challenge in the
naïve group in Expt. 1, with a similar trend in the
immune group, but did not show significant differences
between the two groups (Figure 6). Transcripts for the
chemokine CCL5 (RANTES) were among the most up-
regulated in naïve sheep on day 5 post-challenge (+1.5
Table 4 The 20 most up-regulated transcripts detected in Expts. 1 and 2 (FDR ?≤? 0.05) (Continued)
KN511_9487k02.p1kM13F TC385703 UP|VPS28_MOUSE (Q9D1C8) VPS28 protein homolog (Caspase-activated DNase
inhibitor that interacts with ASK1) (CIIA), complete
VPS28 5.97
KN511_9265g07.p1kaM13F TC351879 — LOC614719 5.84
KN511_9476g04.p1kaM13F TC371801 homologue to SP|O60506|HNRPQ_HUMAN Heterogeneous nuclear
ribonucleoprotein Q (hnRNP Q) (hnRNP-Q)(Synaptotagmin binding, cytoplasmic
RNA interacting protein) (Glycine-and tyrosine-rich RNA binding protein) (GRY-RBP)
(NS1-associatedprotein 1). {Homo sapiens} (exp = -1; wgp = -1; cg = -1), partial
(51%)
SYNCRIP 5.58
KN511_9263f17.p1kaM13F TC355165 similar to UP|Q9XSA0_SHEEP (Q9XSA0) Pulmonary surfactant-associated protein B
(Fragment), partial (16%)
— 4.64
KN511_9476p04.p1kaM13F TC329988 UP|Q5E973_BOVIN (Q5E973) Ribosomal protein L18, complete RPL18 4.47
KN511_9480l18.p1kaM13F TC364833 — — 4.38
KN511_9265h18.p1kaM13F TC303880 homologue to UP|O35328_MOUSE (O35328) Proline-rich protein 9-1 (Fragment),
partial (6%)
— 4.18
KN511_9260b08.p1kaM13F TC330838 – — 4.15
The experiment and the samples being compared are given as subheadings at the top of each section. Nv = “naïve” yearlings, worm naïve prior to challenge; Im
= “immune” yearlings, previously infected by trickle infection prior to challenge, d = days post-challenge. Details of the experimental trials and hybridisation
design are given in Tables 1 and 2.
Knight et al. Veterinary Research 2011, 42:78
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Sequence.ID TIGR_TC TC.description Gene
symbol
Fold
Change
EXPT 1 Comparison = d5Nv_d0Nv
KN511_9487m11.p1kM13F TC336019 UP|MMP13_BOVIN (O77656) Collagenase 3 precursor (Matrix metalloproteinase-13)
(MMP-13), complete
MMP13 -2.68
KN511_9481c03.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -2.37
KN511_9476d13.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -2.33
KN511_9485a08.p1kM13F TC302650 milk lysozyme [Bos taurus] LYZ1 -2.30
KN511_9485g08.p1kM13F TC346615 similar to UP|O97916_BOVIN (O97916) Reverse transcriptase-like, partial (32%) — -2.23
KN511_9257d12.p1kaM13F TC322737 similar to UP|Q3VD89_9SPHN (Q3VD89) ABC-2, partial (5%) — -2.16
KN511_9257a18.p1kaM13F TC308928 similar to GB|AAK18773.1|13324523|F272846S31 Fanconi anemia complementation
group D2 protein, isoform 2 {Homo sapiens} (exp = -1; wgp = 0; cg = 0), partial
(18%)
LOC515845 -2.14
KN511_9262d01.p1kaM13F —— — -2.12
KN511_9261n23.p1kaM13F TC362037 homologue to UP|IFRD1_PIG (Q5S1U6) Interferon-related developmental regulator
1, complete
IFRD1 -2.12
KN511_9476d14.p1kaM13F TC349311 similar to UP|NEK4_HUMAN (P51957) Serine/threonine-protein kinase Nek4 (NimA-
related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-
protein kinase NRK2), partial (33%)
MGC159441 -2.08
KN511_9261o08.p1kaM13F TC305060 homologue to UP|Q96BA7_HUMAN (Q96BA7) HNRPU protein, partial (93%) MGC142835 -2.07
KN511_9258d23.p1kaM13F —— — -2.07
KN511_9487p21.q1kM13R TC342358 homologue to UP|DC1L2_HUMAN (O43237) Cytoplasmic dynein 1 light
intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC53/55) (LIC-
2), complete
LOC519789 -2.05
KN511_9262k18.p1kaM13F TC375209 similar to UP|ZSWM3_HUMAN (Q96MP5) Zinc finger SWIM domain-containing
protein 3, partial (27%)
LOC512244 -2.05
KN511_9485d23.q1kM13R TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -2.04
KN511_9254g13.p1kaM13F TC319944 — — -2.02
KN511_9487h17.p1kM13F TC327406 UP|Q5DTN6_MOUSE (Q5DTN6) MKIAA4095 protein (Fragment), partial (8%) LOC614823 -1.96
CO202908 TC360504 UP|Q3MHM4_BOVIN (Q3MHM4) Heat shock 70 kDa protein 8, complete HSPA8 -1.87
KN511_9482g13.p1kM13F TC331274 homologue to UP|TENA_PIG (Q29116) Tenascin precursor (TN) (Hexabrachion)
(Cytotactin) (Neuronectin) (GMEM) (JI) (Miotendinous antigen) (Glioma-associated-
extracellular matrix antigen) (GP 150-225) (Tenascin-C) (TN-C) (P230), partial (10%)
MGC140517 -1.87
KN511_9482f05.p1kM13F TC377013 — — -1.86
EXPT 1 Comparison = d5Im_d5Nv
KN511_9256g17.p1kaM13F TC314535 homologue to UP|Q94513_DROME (Q94513) Boundary element associated factor
(LD44361p) (CG10159-PB, isoform B), partial (5%)
— -6.51
KN511_9256g17.p1kaM13F TC314535 homologue to UP|Q94513_DROME (Q94513) Boundary element associated factor
(LD44361p) (CG10159-PB, isoform B), partial (5%)
— -5.97
KN511_9254l23.p1kaM13F TC354719 similar to UP|TFF2_HUMAN (Q03403) Trefoil factor 2 precursor (Spasmolytic
polypeptide) (SP) (Spasmolysin), complete
MGC139191 -5.54
KN511_9257l15.p1kaM13F TC354719 similar to UP|TFF2_HUMAN (Q03403) Trefoil factor 2 precursor (Spasmolytic
polypeptide) (SP) (Spasmolysin), complete
MGC139191 -5.42
KN511_9260b10.p1kaM13F TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.92
KN511_9260m19.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.79
KN511_9483j03.p1kM13F TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.52
KN511_9265j02.p1kaM13F CB220717 — — -3.45
KN511_9264e04.p1kaM13F TC314849 UP|Q6SJV6_BOVIN (Q6SJV6) Foveolin precursor, complete FOV -3.33
KN511_9262k17.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.25
KN511_9476c18.p1kaM13F TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.25
Knight et al. Veterinary Research 2011, 42:78
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KN511_9476d13.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.17
KN511_9488a15.p1kM13F TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.16
KN511_9259k01.p1kaM13F TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.14
KN511_9265m20.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.10
KN511_9263j17.p1kaM13F TC323852 similar to UP|Q86XP6_HUMAN (Q86XP6) GDDR (Blottin precursor) (TFIZ1 protein
precursor), complete
LOC512001 -3.10
KN511_9487e19.p1kM13F TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.08
KN511_9485d23.q1kM13R TC365645 UP|LYSC2_BOVIN (Q06283) Lysozyme C-2 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -3.05
KN511_9486h17.p1kM13F TC314849 UP|Q6SJV6_BOVIN (Q6SJV6) Foveolin precursor, complete FOV -3.04
KN511_9265h22.p1kaM13F TC304583 UP|LYSC1_BOVIN (Q06285) Lysozyme C-1 precursor (1,4-beta-N-acetylmuramidase
C), complete
LYZ2 -2.99
EXPT 2 Comparison = Day 0 Im vs Day 0 Nv
KN511_9484p13.p1kM13F TC376600 similar to UP|CENPA_MOUSE (O35216) Centromere protein A (CENP-A) (Centromere
autoantigen A), partial (15%)
CENP-A -1.75
KN511_9479i16.p1kaM13F —— — -1.75
KN511_9253l11.p1kaM13F TC303509 homologue to UP|RIR2_HUMAN (P31350) Ribonucleoside-diphosphate reductase
M2 subunit (Ribonucleotide reductase small subunit) (Ribonucleotide reductase
small chain), partial (88%)
RRM2 -1.73
KN511_9488d17.p1kM13F TC314207 similar to UP|TOP2A_PIG (O46374) DNA topoisomerase 2-alpha (DNA
topoisomerase II, alpha isozyme), partial (17%)
TOP2A -1.71
KN511_9265l09.p1kaM13F TC340393 UP|CCNA2_BOVIN (P30274) Cyclin-A2 (Cyclin-A) (Fragment), complete CCNA2 -1.70
KN511_9488f20.p1kM13F TC355225 homologue to UP|BIRC5_CANFA (Q8I009) Baculoviral IAP repeat-containing protein
5 (Apoptosis inhibitor survivin), complete
BIRC5 -1.66
KN511_9487m04.p1kM13F TC355225 homologue to UP|BIRC5_CANFA (Q8I009) Baculoviral IAP repeat-containing protein
5 (Apoptosis inhibitor survivin), complete
BIRC5 -1.65
KN511_9253i15.p1kaM13F TC340307 UP|CP51A_BOVIN (Q4PJW3) Cytochrome P450 51A1 (CYPLI) (P450LI) (Sterol 14-alpha
demethylase) (Lanosterol 14-alpha demethylase) (LDM) (P450-14DM) (P45014DM),
complete
CYP51 -1.63
KN511_9265a16.p1kaM13F TC303827 — KIF11 -1.58
KN511_9264b09.p1kaM13F —— — -1.56
KN511_9256j19.p1kaM13F TC355225 homologue to UP|BIRC5_CANFA (Q8I009) Baculoviral IAP repeat-containing protein
5 (Apoptosis inhibitor survivin), complete
BIRC5 -1.53
KN511_9261d22.p1kaM13F —— — -1.50
KN511_9481l06.p1kaM13F TC303509 homologue to UP|RIR2_HUMAN (P31350) Ribonucleoside-diphosphate reductase
M2 subunit (Ribonucleotide reductase small subunit) (Ribonucleotide reductase
small chain), partial (88%)
LOC508167 -1.49
KN511_9476j14.p1kaM13F TC333525 homologue to GB|AAH08056.2|39644830|BC008056 PLEK2 protein {Homo sapiens}
(exp = -1; wgp = 0; cg = 0), partial (21%)
MGC142714 -1.48
KN511_9482e10.p1kM13F TC330132 similar to UP|CV106_HUMAN (Q6P0N0) Protein C14orf106 (P243), partial (33%) LOC507661 -1.47
KN511_9257p16.p1kaM13F TC340307 UP|CP51A_BOVIN (Q4PJW3) Cytochrome P450 51A1 (CYPLI) (P450LI) (Sterol 14-alpha
demethylase) (Lanosterol 14-alpha demethylase) (LDM) (P450-14DM) (P45014DM),
complete
CYP51 -1.46
KN511_9256f06.p1kaM13F TC332145 similar to UP|Q9BDH4_PIG (Q9BDH4) Amphiregulin long form, complete MGC152310 -1.45
CN824006 TC306385 homologue to UP|Q4S6A0_TETNG (Q4S6A0) Chromosome 9 SCAF14729, whole
genome shotgun sequence, partial (59%)
LOC404053 -1.42
KN511_9257i02.p1kaM13F TC327524 homologue to UP|Q9BW51_HUMAN (Q9BW51) TTK protein kinase, partial (44%) LOC524925 -1.41
KN511_9261e22.p1kaM13F TC301804 homologue to UP|IMA2_HUMAN (P52292) Importin alpha-2 subunit (Karyopherin
alpha-2 subunit) (SRP1-alpha) (RAG cohort protein 1), complete
KPNA2 -1.41
EXPT 2 Comparison = Day 2 Im vs Day 0 Im
KN511_9479k18.p1kaM13F CX950602 — — -3.53
KN511_9488b02.p1kM13F DY126632 — — -3.24
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Page 11 of 22fold; Figure 3d)), and were up-regulated in immune
sheep compared to naive at this timepoint (+1.4 fold).
Gene expression of several members of the comple-
ment cascade also appear to be up-regulated in response
to T. circumcincta challenge. Complement factor 1
(CF1), and other members of the classical C1-complex,
were significantly (FDR ≤ 0.05) up-regulated in immune
sheep in response to challenge by day 2 (+2-3 fold), but
not in naïve animals (Table 4 and Figure 3d)). The
“Complement System” was the third most significant
pathway identified from the Imd2/Imd0 comparison
(Figure 2), and the most significant pathway within the
Network 1 subset from this comparison (Additional file
2 Table S3). However, the multiplex qRT-PCR analysis
specific for complement factor 1 did not show the same
pattern of expression detected in the arrays, with a lot
of sheep-to-sheep variation, although there was a clear
trend towards up-regulated gene expression in response
to challenge in both groups in Expt. 1 (Figure 6).
Matrix metalloproteinases and protease inhibitors
Transcripts for the matrix metalloproteinase MMP-23B
were significantly (FDR ≤ 0/05) up-regulated (+1.7 fold)
in immune versus naïve sheep on day 5 pi in the
microarray analysis (Figure 3e), while MMP-13 was
down-regulated (-2.3 fold) in the immune group com-
p a r e dt on a i v ea td a y5p o s t - c h a l l e n g e( F i g u r e3 ea n d
Table 5). There was also significant up-regulation of the
protease inhibitor cystatin C (CST3) in immune sheep
compared to naïve at day 0 and day 5 post-challenge
(+1.4/+1.5 fold) (Figure 3e and Table 5). The multiplex
qRT-PCR analysis confirmed transcripts for MMP-13
were expressed at significantly (P ≤ 0.05) lower levels in
immune versus naïve sheep at day 0, while MMP23B
gene expression showed a similar pattern at day 2 pi (P
≤ 0.05; immune vs. naive) (Figure 6). Transcripts for
cystatin C appeared to be expressed at high but fairly
consistent levels in both groups, although significantly
higher levels were detected in naïve sheep than immune
sheep at day 2 post-challenge (Figure 6).
Immunoglobulins
Genes featuring the “immunoglobulin” descriptor occur
31 times among the significantly (FDR ≤ 0.05) up-regu-
lated transcripts in immune animals on day 5 post-chal-
lenge compared to day 5 naïve, and 13 times in the day
2 immune versus day 0 immune group (see [34] for
complete dataset).
Table 5 The 20 most down-regulated transcripts detected in Expts 1 and 2 (FDR ?≤? 0.05) (Continued)
KN511_9257l15.p1kaM13F TC354719 similar to UP|TFF2_HUMAN (Q03403) Trefoil factor 2 precursor (Spasmolytic
polypeptide) (SP) (Spasmolysin), complete
TFF2 -3.14
KN511_9254l23.p1kaM13F TC354719 similar to UP|TFF2_HUMAN (Q03403) Trefoil factor 2 precursor (Spasmolytic
polypeptide) (SP) (Spasmolysin), complete
TFF2 -3.03
KN511_9264e04.p1kaM13F TC314849 UP|Q6SJV6_BOVIN (Q6SJV6) Foveolin precursor, complete FOV -2.81
KN511_9263j17.p1kaM13F TC323852 similar to UP|Q86XP6_HUMAN (Q86XP6) GDDR (Blottin precursor) (TFIZ1 protein
precursor), complete
GKN2 -2.45
KN511_9486h17.p1kM13F TC314849 UP|Q6SJV6_BOVIN (Q6SJV6) Foveolin precursor, complete FOV -2.09
KN511_9261k22.p1kaM13F TC327109 similar to UP|O97916_BOVIN (O97916) Reverse transcriptase-like, partial (21%) — -1.93
KN511_9486b13.p1kM13F TC341767 — — -1.90
KN511_9484h13.p1kM13F TC350450 similar to UP|UDB5_MOUSE (P17717) UDP-glucuronosyltransferase 2B5 precursor
(UDPGT) (M-1), partial (49%)
UGT2B17 -1.81
KN511_9263c22.p1kaM13F —— — -1.80
KN511_9264a19.p1kaM13F —— — -1.77
KN511_9484l14.p1kM13F TC362885 similar to UP|MALAT_HUMAN (Q9UHZ2) Metastasis-associated lung
adenocarcinoma transcript 1, partial (72%)
MALAT1 -1.75
KN511_9480l06.p1kaM13F TC362885 similar to UP|MALAT_HUMAN (Q9UHZ2) Metastasis-associated lung
adenocarcinoma transcript 1, partial (72%)
MALAT1 -1.74
KN511_9481o23.p1kaM13F TC350450 similar to UP|UDB5_MOUSE (P17717) UDP-glucuronosyltransferase 2B5 precursor
(UDPGT) (M-1), partial (49%)
UGT2B17 -1.73
CN824758 —— — -1.72
KN511_9488a17.p1kM13F TC318925 — — -1.71
KN511_9480o03.p1kaM13F —— — -1.70
KN511_9263o20.p1kaM13F TC380127 similar to UP|UDB5_MOUSE (P17717) UDP-glucuronosyltransferase 2B5 precursor
(UDPGT) (M-1), partial (42%)
UGT2B17 -1.70
KN511_9484i14.p1kM13F TC362885 similar to UP|MALAT_HUMAN (Q9UHZ2) Metastasis-associated lung
adenocarcinoma transcript 1, partial (72%)
MALAT1 -1.67
The experiment and the samples being compared are given as subheadings at the top of each section. Nv = “naïve” yearlings, worm naïve prior to challenge; Im
= “immune” yearlings, previously infected by trickle infection prior to challenge, d = days post-challenge. Details of the experimental trials and hybridisation
design are given in Tables 1 and 2.
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Members of the gastric lysozyme family [38] were the
most consistently down-regulated transcripts (FDR ≤
0.05) detected in the Expt. 1 microarray analyses (day 5
post-challenge) (Figure 3f and Table 5). RT-PCR and
sequence analysis have previously indicated infection-
associated down-regulation of transcripts for the ovine
gastric lysozyme genes 1A, 2A, 3A and 4A, and con-
firmed these transcripts all exhibited some level of poly-
morphism (Anderson and Knight; data not shown).
Gastric lysozymes 1A and 4A were selected for further
analysis in the multiplex qRT-PCR assay (Table 3). This
analysis confirmed that transcripts for lysozymes 1A and
4A were both highly expressed in the naïve abomasum
Figure 3 Key changes detected in Expt. 1 (day 5 post-challenge) and Expt. 2 (day 2 post-challenge). Summary of mean infection-
associated fold changes in the expression levels of key groups of transcripts detected from the microarray analyses. Transcripts are grouped as
follows according to associated function/cell type; a) cytotoxicity, b) mucus composition, c) heat shock response, d) proinflammatory response, e)
tissue remodelling (matrix metalloproteinases and inhibitors), f) nutritional (lysozyme family), g) unknown (MALAT). The groups being compared
are indicated on the y-axis.
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Page 13 of 22and were significantly (P ≤ 0.05-0.005) down-regulated
in immune versus naïve sheep at days 2 and 5 post-chal-
lenge, although these differences became less apparent
from day 10 onwards as levels in the naïve animals
reduced (Figure 7).
MALAT-1
Metastasis-associated lung adenocarcinoma transcript 1
(MALAT-1) was identified as among the most signifi-
cantly (FDR ≤ 0.05) down-regulated transcripts in
immune sheep on day 2 post-challenge (-1.8-2 fold),
compared to naïve animals or day 0 (Table 4 and Figure
3g). This observation from the array data was confirmed
by the multiplex qRT-PCR analysis, with significantly
reduced levels of MALAT-1 transcripts in immune ver-
sus naïve animals at day 0 and day 2 post-challenge
(Figure 7). MALAT-1 is understood to be a novel non-
coding RNA which is highly conserved across species
and up-regulated during metastasis, but its function is
unknown to date [39]. We also observed transcripts for
“boundary element associated factor” as the most highly
down-regulated transcript in immune versus naïve ani-
mals at day 5 post-challenge (-6.5 fold, Table 5); again
the function of this gene product is not clear but it
appears to be involved in transcriptional regulation by
compartmentalization of the genome [40].
Discussion
The molecular mechanisms that contribute to protec-
tion from gastrointestinal nematodes have been exten-
sively investigated in rodent models (e.g. reviews by
[41-43]), but progress in understanding the responses to
natural infections in ruminants, especially sheep, has
been slower partly due to the limited range of appropri-
ate species-specific reagents and genomics tools. Here
we summarise findings using a novel ovine cDNA
microarray, which is the first global transcriptomic ana-
lysis of ovine immune responses to Teladorsagia circum-
cincta challenge. Our data presented here are consistent
with the observed increased adaptive and innate
immune response taking place by days 2 and 5 post-
challenge in the abomasal mucosa of sheep previously
exposed to the parasite using this experimental protocol
[11]. As discussed below, many of our findings highlight
the importance of genes which have been investigated in
rodent models of gastrointestinal nematode infection
and previously highlighted in other ruminant studies,
such as the expression changes in immunoglobulin
Figure 4 Results of competitive multiplex qRT-PCR analysis to investigate temporal changes in the expression levels of transcripts
normally associated with cells exhibiting cytotoxicity; granulysin, granzymes A, B and H, and cathepsin C, as indicated, throughout
the experiment trials summarised in Table 1. Open circles represent data from naïve sheep; closed triangles represent data from immune
("previously infected”) sheep. Significant difference between Nv and Im at same timepoint; *P ≤ 0.05, **P ≤ 0.005, ***P ≤ 0.005; Significant
difference between timepoint and day 0 of same group (where available);
+P ≤ 0.05,
++P ≤ 0.005,
+++P ≤ 0.005 (Mann-Whitney U-test for non-
parametric data). NB.- data for granzyme H- model fitting failed in some samples, so n = 5 in some groups as indicated.
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of the arachidonic acid pathway, and point to common
mechanisms operating in response to nematode parasit-
ism of both the gastric and intestinal mucosa. However,
we have also highlighted novel changes such as altered
expression levels of granulysin, gastric lysozymes, mem-
bers of the matrix-metalloprotease family, and STIP1,
which indicate responses that are unique to this model
or have not been identified to date.
As reported previously, in all the trials (Table 1),
sheep immunised by previous infection ("immune”)h a d
significantly (P ≤ 0.01) lower worm burdens than naïve
animals at the same timepoint, even at 48 h post-chal-
lenge [4,11]. Similarly, worms recovered from the immu-
nised sheep showed higher levels of stunting [4]. These
observations confirmed there were significantly
increased anti-parasite responses in the immunised
groups compared to naïve, and that these responses
manifested themselves within 48 h of challenge. Pre-
vious work using materials from these infection trials
indicated that there were clear histological and/or histo-
chemical phenotypic differences elicited in the host
response between the “naïve” and “immune” groups,
such as mucosal hypertrophy, mast cell and eosinophil
counts, and in mucous composition ([8,44] and Craig et
al., unpublished observations). In order to characterise
these differences at a molecular level we examined
changes in gene expression at the transcript level in the
same experimental animals.
There were some discrepancies in this study between
the findings from the cDNA arrays and the multiplex
qRT-PCR results, which is likely to be due, in part, to
the inability of some of the cDNA probes (+400bp) to
distinguish between groups of highly similar genes. This
is particularly obvious in the case of the highly similar
family of ruminant gastric lysozyme genes [38]; only the
specific RT-PCR/competitive qRT-PCR techniques
would have been able to reliably distinguish between
transcripts for lysozymes 1A and 4A, which are 92%
identical at the DNA level. A similar explanation is
likely to account for inconsistencies between the micro-
array and qRT-PCR findings in identifying changes in
transcripts for members of the C1 complement family,
and for the ITLN genes 1, 2 and 3, which were unlikely
Figure 5 Results of competitive multiplex qRT-PCR analysis to investigate temporal changes in the expression levels of mucous-cell
associated transcripts; CLCA1 and ITLNs 1-3, as indicated, throughout the experiment trials summarised in Table 1. Open circles
represent data from naïve sheep; closed triangles represent data from immune ("previously infected”) sheep. Significant difference between Nv
and Im at same timepoint; *P ≤ 0.05, **P ≤ 0.005, ***P ≤ 0.005; Significant difference between timepoint and day 0 of same group (where
available);
+P ≤ 0.05,
++P ≤ 0.005,
+++P ≤ 0.005 (Mann-Whitney U-test for non-parametric data).
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array; there were also temporal differences in expression
between the three genes (Figure 5). These findings high-
light the importance of validation of cDNA array data
by more sensitive techniques, such as quantitative PCR-
based analyses.
As immunity to T. circumcincta is associated with
local IgA and IgE responses typical of gastrointestinal
nematode infections [4,6] it is unsurprising that genes
featuring the “immunoglobulin” descriptor were highly
represented among the significantly up-regulated
transcripts in immune animals. Our findings for immu-
noglobulin transcripts are consistent both with an
increased adaptive response in sheep previously exposed
to the parasite, and with observations from other global
analyses of responses to gastrointestinal nematode infec-
tion [45-47].
Our findings highlight the universal importance of
mucus components in mammalian responses to parasitic
nematode infection, such as CLCA1, members of the
ITLN family and trefoil factor 3, which potentially con-
tribute to expulsion by altering mucus composition and
Figure 6 Results of competitive multiplex qRT-PCR analysis to investigate temporal changes in the expression levels of a number of
transcripts associated with tissue remodelling or inflammatory responses throughout the experiment trials summarised in Table 1.
Data is shown for heat shock proteins HSPA8, HSPCA and STIP1; transcripts associated with pro-inflammatory responses CCL2, PLA2G2A and CF1,
and matrix metalloproteinases and inhibitors MMP-13, MMP-23 and cystatin C, as indicated. Open circles represent data from naïve sheep; closed
triangles represent data from immune ("previously infected”) sheep. Significant difference between Nv and Im at same timepoint; *P ≤ 0.05, **P
≤ 0.005, ***P ≤ 0.005; Significant difference between timepoint and day 0 of same group (where available);
+P ≤ 0.05,
++P ≤ 0.005,
+++P ≤ 0.005
(Mann-Whitney U-test for non-parametric data).
Knight et al. Veterinary Research 2011, 42:78
http://www.veterinaryresearch.org/content/42/1/78
Page 16 of 22making the environment of the parasite inhospitable. A
similar pattern of gene expression has been identified in
response of the abomasal mucosa to Haemonchus con-
tortus infection [46]. There is a clear association
between intestinal goblet cell hyperplasia, release of
their effector molecules and altered mucus composition
with the trapping and expulsion of gastrointestinal
nematodes, mostly based on murine studies (reviewed
by [43,48,49]. Sheep given trickle infection of T. circum-
cincta are known to exhibit hyperplasia of mucous-neck
cells [14], which are phenotypically similar to goblet
cells in the intestine, but this occurs as a later event in
naïve sheep in response to challenge [10]. Previous work
[44] has also demonstrated differences in PAS staining
in naïve versus immune sheep (P < 0.05, Kruskall-Wallis
at day 10 post-challenge) from the experimental samples
used in this study, indicating altered abomasal mucous
composition between the two groups.
CLCA1 ( t h ep u t a t i v eo r t h o l o g u eo fCLCA3 in mice),
which featured as one of the most consistently up-regu-
lated transcripts in immune sheep, is secreted by goblet/
mucous-neck cells in association with Th2-type inflam-
matory responses, such as murine models of pulmonary
inflammation and gastro-intestinal nematode infection
[50]. We have confirmed that CLCA1 is up-regulated by
IL-4 and IL-13 in a human goblet cell line [43], and by
IL-4 in ovine gastric epithelial cells (Knight et al., in pre-
paration). The significant up-regulation of transcripts for
the mucous cell product trefoil factor 3 (TFF3)i n
immune animals compared to naïve was in contrast to
TFF2, which is highly down-regulated (Tables 4 and 5).
TFF3 is IL-4/IL-13-regulated and interacts with the
m u c i nM U C 2( n o to na r r a y )t o alter mucus viscosity,
with which it co-localises in human intestinal goblet
cells, and up-regulation of both these mucus compo-
nents has been associated with responses to nematode
infection in mice (reviewed by [43]). Up-regulation of
TFF3 and down-regulation of TFF2 transcripts has also
been demonstrated in the abomasal mucosa of sheep
during the response to H. contortus [46,51,52], thus
switching to a more “intestinal” phenotype in terms of
TFF expression.
The multiplex qRT-PCR analyses showed the galac-
tose-binding lectins ITLNs 1, 2 and 3 were significantly
up-regulated in response to challenge in naïve sheep,
with earlier up-regulation of ITLN3 than ITLNs- 1a n d
-2 (Figure 5). ITLN protein is localised to mucous neck
cells in the abomasal mucosa, and highly up-regulated
in infected compared to worm-free naïve sheep [27,35].
We also observed infection-associated up-regulation of
transcripts for two other galactose-binding lectins;
galectin 1, which is thought to bind gastrointestinal
mucins [53], and galectin 4, which has been shown to
be localised to gastric mucous cells in mice [54]. There
is a clear temporal association between expression of
members of the intelectin family by murine intestinal
goblet cells and resistance to gastrointestinal nematode
infection in mice [55,56]. The ITLN family, like CLCA1,
are highly regulated by Th2 cytokines in murine and
human goblet cells [43], and this has also been con-
firmed in ovine tracheal goblet cells [57] and gastric
epithelial cultures (Knight et al, in preparation). Both
CLCA1 and intelectin protein were up-regulated in
mucosal washings from previously infected, but not
naïve, animals [58] indicating they act concordantly as
part of an increased Th2-type response to alter mucus
composition. It is possible that members of both the
intelectin and galectin family are involved in interaction
with mucins to change the rheological properties or
adhesiveness of the mucus, and/or adhere to the worms
to exert effector function or target them for immune
clearance.
Significant up-regulation of the high affinity IgE recep-
tor in immune animals day 2 and day 5 post-challenge,
Figure 7 Results of competitive multiplex qRT-PCR analysis to investigate temporal changes in the expression levels of transcripts for
lysozymes 1A and 4A, and MALAT, as indicated, throughout the experiment trials summarised in Table 1. Open circles represent data
from naïve sheep; closed triangles represent data from immune ("previously infected”) sheep. Significant difference between Nv and Im at same
timepoint; *P ≤ 0.05, **P ≤ 0.005, ***P ≤ 0.005; Significant difference between timepoint and day 0 of same group (where available);
+P ≤ 0.05,
+
+P ≤ 0.005,
+++P ≤ 0.005 (Mann-Whitney U-test for non-parametric data).
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with an increased mast cell response in this group. T-
cell mediated mucosal mast cell hyperplasia, accompa-
nied by release of mast-cell mediators, is a characteristic
feature of gastrointestinal nematode infections in mam-
mals (reviewed by [43,59]). While numbers of mast cells
(globule leucocytes) in the ovine abomasal mucosa are
normally very low in uninfected sheep, they markedly
increase in response to T. circumcincta infection in sen-
sitised sheep, accompanied by release of sheep mast cell
protease (SMCP) [13,60]. An assessment of the samples
used in this study confirmed that the immune group
had significantly higher numbers of mast cells than the
naïve group at days 0, 2, 5 and 10 post-challenge, with
the naïve animals showing very little increase in mucosal
mast cell numbers in response to challenge ([8] and
Craig et al., unpublished data).
We see evidence of up-regulation of a number of tran-
scripts associated with eicosanoid metabolism, in parti-
cular PLA2G2A, which can initiate and regulate
inflammation [61]. Increased synthesis of phospholipase
and other members of the arachidonic acid cascade have
been associated with intestinal nematode infection in
rodents, cattle and swine [62-66], and so are likely to
play a common key role in the induction and/or regula-
tion of nematode-induced allergic inflammation; we
would postulate a similar set of events occurring in the
o v i n ea b o m a s a lm u c o s ai nr e s p o n s et op a r a s i t ec h a l -
lenge. Members of the complement cascade also appear
to be up-regulated in response to T. circumcincta chal-
lenge; up-regulation of the complement C1 and C4 has
similarly been linked to resistance to intestinal nema-
tode infection in cattle [65]. Complement activation
serves to initiate and propagate pro-inflammatory
responses, although the role of complement in immu-
nity to parasitic helminths is unclear [67]. Proteomic
analysis has indicated complement and other plasma
proteins are up-regulated in the mucosa of T. circum-
cinta infected versus naïve sheep, although these are
likely to be derived from plasma rather than local
expression [58].
We observed significant up-regulation of the chemo-
kines CCL2 and CCL5 in response to larval challenge
(Table 4, Figures 3c) and 6). CCL2, which is produced
by a range of cell types including mast cells [68] has
been shown to be released locally in response to gastro-
intestinal nematode infection in mice, and has been
implicated in resistance to Trichuris muris by steering
towards a Th2-type response [69]. CCL5 is chemotactic
for T cells, eosinophils, and basophils and implicated in
a wide range of inflammatory diseases [70]. A previous
RT-PCR-based analysis has shown that the abomasal
mucosa is a source for a range of chemokine transcripts,
and that CCL5 transcripts are up-regulated in response
to T. circumcincta challenge (Griffith et al., unpublished
observations).
One of the most surprising findings from this study,
which has not been evidenced from rodent models, is
the striking up-regulation of transcripts for granulysin in
immune animals, which is normally associated with anti-
microbial activity [71], along with other transcripts
(granzymes, cathepsin C) normally associated with lym-
phocytes exhibiting cytotoxicity. Granulysin and NK-
lysin are secreted, antimicrobial lipid-binding proteins
belonging to the saposin family [71]. They have been
identified in human, swine and bovine cytotoxic T lym-
phocytes and natural killer (NK) cells [72,73], but no
murine counterpart has been identified to date. Granuly-
sin is active against a broad range of intracellular and
extracellular microbes [74], and granulysin activity has
also been associated with apoptosis and necrosis of kera-
tinocytes [75]. Granzymes A, B and H, like granulysin,
a r ea l s on o r m a l l ya s s o c i a t e dw i t ht h ea c t i v i t yo fc y t o -
toxic T-cells and NK cells [76], while cathepsin C is
required for the processing and correct functioning of
granzymes A and B and mast cell proteinases [77].
Interestingly, the pattern of expression of granulysin
transcripts did not closely parallel that of the granzymes
and cathepsin C (Figure 4), which suggests a different
cellular source in the abomasal mucosa. This is the first
time this molecule has been associated with gastrointest-
inal nematode infection, and the first association of this
molecule with ovine disease. We have recently con-
firmed increased levels of granulysin protein in the abo-
masal mucosa of immune, but not naïve, sheep, and the
potential biological role of granulysin in nematode infec-
tion is under further investigation (Griffith et al, in
preparation).
Expression levels of transcripts for a number of heat
shock proteins were significantly altered in the microar-
ray analyses; in particular STIP1, which facilitates the
association of the HSP70/90 complex which is impli-
cated in the folding/regulation of a range of signalling
proteins [78], was significantly increased in response to
challenge (Figure 6). Host heat shock proteins are
expressed constitutively in all cells but synthesis is
increased in response to certain stressors or infection
[79]. There has been little evidence to identify a direct
role for heat shock proteins in gastrointestinal nematode
infection, although T. spiralis has been shown to elicit
host heat shock protein production during muscle
migration [80]. The up-regulation and/or release of heat
shock proteins is likely to be solely the effect of cellular
damage caused to the mucosa by the parasite, but their
release may also activate immune cells or facilitate anti-
gen presentation [79,81].
Both the microarray and multiplex qRT-PCR analysis
demonstrated significant down-regulation of transcripts
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tin C transcript expression. In a separate study (Knight
et al., unpublished data), we have detected markedly
decreased levels of transcripts for MMP-7 and TIMP-1
(tissue inhibitor of metalloproteinases) in immune ver-
sus naïve sheep exposed to T. circumcincta (MMP-7
and TIMP-1 were not this on array). Matrix metallopro-
teinases are implicated in a wide range of processes
including regulation of inflammatory responses such as
modulating response to cytokines and activation of b-
defensins, as well as tissue dissolution/remodelling
[82,83] and have been associated with T-cell mediated
t i s s u ed a m a g et ot h eg u tm u c o s a[ 8 4 ] .T h ea p p a r e n t l y
higher levels of these transcripts in naïve compared to
immune sheep may reflect increased tissue damage that
is generally observed in the abomasa of animals that
have not built up a level of immunity to the parasite. It
is also possible that they have a role in inflammatory
processes/tissue remodelling that is “replaced” in pre-
viously exposed sheep by mast cell proteases, which
may have a similar function [85], following expansion of
the mucosal mast cell population. The altered profile in
matrix metalloproteinases may also have implications in
interaction with incoming larvae, as helminth parasites
are understood to produce proteinase inhibitors to pro-
tect themselves from degradation by host proteinases
[86], and parasites of the gastrointestinal tract can inter-
act with host proteolytic pathways with immunomodu-
latory effects [87,88]. Furthermore, T. circumcincta
larvae abundantly produce the cysteine protease cathe-
psin F [89], which raises the possibility that high local
levels of cystatin C could serve a protective function.
The potential interaction of these matrix-metallopro-
teases and protease inhibitors with proteases or inhibi-
tors produced by incoming larvae would merit further
investigation.
The most consistently down-regulated transcripts in
immune versus naïve sheep detected at day 5 post-chal-
l e n g ew e r em e m b e r so ft h er u m i n a n tg a s t r i cl y s o z y m e
family. It should be noted that the array contained more
than 50 spots representing members of this family which
were down-regulated in the day 5 immune vs. naïve com-
p a r i s o n ,a n d5s p o t si nt h ed a y5n a ï v ev s .d a y0n a ï v e
comparison. The large numbers of significant spots may
be partly due to the overrepresentation of the lysozyme
family on the cDNA chip, having a high proportion of
sequences in the KN511 library (2.5%) [90]. There are
four highly similar ruminant gastric lysozyme genes,
which are thought to have evolved from the lysozyme C
gene family by gene-duplication events [38]. They are
highly expressed in the ovine abomasum and are thought
to act as a major digestive enzyme, functional at low pH,
for the large amounts of bacteria entering from the
rumen, by breaking down peptidoglycan cell walls which
cannot be hydrolysed by conventional digestive enzymes.
This analysis confirmed that transcripts for lysozymes 1A
and 4A were both highly expressed in the naïve aboma-
sum and significantly down-regulated in immune versus
naïve sheep at days 2 and 5 post-challenge, although
these differences became less apparent from day 10
onwards as levels in the naïve animals reduced (Figure 7).
This pattern is in contrast to a parallel proteomics study,
where lysozyme 4A increased in previously infected ani-
mals compared to naïve at day 0 and day 2 post-challenge
(Brown, Pemberton et al., in preparation) and members
o ft h el y s o z y m ef a m i l yw e r ef ound to be up-regulated in
abomasal epithelial extracts and mucosal washes from
previously infected versus naïve sheep [58]. This disparity
is likely to be due to differing rates of transcription, pro-
cessing and storage of the gastric lysozymes prior to
secretion. Sheep parasitized by T. circumcincta show
diminution of parietal cell number, raised abomasal pH
and hypergastrinaemia [14,91], so we could speculate
that the alterations in lysozyme production, and the pos-
sible inability of lysozymes to function in the raised pH
of the abomasum, both reflect these changes and may
contribute to the resultant nutritional loss seen in
infected animals.
In summary, the up-regulated expression of mucous-
cell related transcripts such as CLCA1, TFF3 and ITLNs,
as well as transcripts for the high affinity IgE receptor,
CCL2, and members of the arachidonic acid pathway in
response to ovine gastric nematode infection, parallel
findings from mouse models of intestinal nematode
infection by ourselves and others [43,56,92]. Many of
these changes reflect a common Th2-driven immune
response occurring across species and in both areas of
the gastrointestinal tract. However, other findings point
to novel changes, such as the distinct local up-regulation
of granulysin in immune sheep, a gene which is present
in humans, cattle and pigs but not mice, and the altera-
tion in the gastric lysozyme profile which is unique to
ruminants.
As can be seen from the pattern of expression of the
gastric lysozymes discussed previously, it needs to be
borne in mind that changes in the transcriptome may
not directly reflect contemporaneous changes in local
levels of the corresponding protein, many of which are
stored before subsequent release into the local microen-
vironment. Many of the changes described here are
likely to reflect the pronounced cellular changes in the
abomasal mucosa induced by exposure to T. circum-
cincta larvae. Nevertheless, the data presented here gives
valuable insights into some of the molecular mechan-
isms that may be operating at the ovine host-parasite
interface to control gastric nematode infection.
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Additional file 1: Table S1 Details of primers and PCR conditions
used for RT-PCR analysis. Details of primers and PCR conditions used
for RT-PCR analysis, and sequences used to design PCR probes. Table S2
Total numbers of genes whose expression levels were significantly
altered detected in each hybridisation experiment Total numbers of
genes whose expression levels were significantly altered (Benjamini &
Hochberg FDR ≤0.05) detected in each hybridisation experiment; (Table
S2a: Expt.1; day 5 post-challenge and Table S2b: Expt. 2; day 2 post-
challenge) including dye interactions.
Additional file 2: Table S3 Significantly highly represented networks
identified using Ingenuity Pathways Analysis software (Ingenuity
®®
Systems, [26]). Networks that were significantly highly represented
(P≤10-10; Fischer’s exact test) identified from the Imd0/Nvd0 and Imd2/
Imd0 datasets from Expt. 2 (see Table II), using Ingenuity Pathways
Analysis software (Ingenuity
®® Systems, [26]). Table S4 Canonical
pathways identified using Ingenuity Pathways Analysis software
(Ingenuity
®® Systems, http://www.ingenuity.com). The top 20 most
significant canonical pathways from the Imd0/Nvd0 and Imd2/Imd0
datasets from Expt. 2 (See Table II), identified using Ingenuity Pathways
Analysis software (Ingenuity
®® Systems, [26]), are shown.
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